On December 12, 2019 Physicians’ Education Resource (PER), the nation’s leading resource for oncology and hematology continuing medical education (CME), reported that it will host the 17th Annual Winter Lung Cancer Conference, Feb. 7-9, 2020, at Eden Roc Miami Beach in Miami Beach, Florida (Press release, Physicians’ Education Resource, DEC 12, 2019, View Source [SID1234552328]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"We know this one-of-a-kind meeting will be one of the premier educational events to learn state-of-the-art care for patients with lung cancers," said Phil Talamo, president of PER. "Our world-class CME conference not only allows our participants to learn, but to share their personal experiences and best practices in lung cancer management."
The historic Winter Lung Cancer Conference will be co-chaired by Rogerio C. Lilenbaum, M.D., professor of medicine in medical oncology and chief medical officer of Smilow Cancer Hospital, Yale New Haven Health; Mark A. Socinski, M.D., executive medical director at Florida Hospital Cancer Institute and AdventHealth Cancer Institute; Heather A. Wakelee, M.D., professor of medicine (oncology) at Stanford University Medical Center; and Julie R. Brahmer, M.D., M.Sc., FASCO, co-director, upper aerodigestive department, Bloomberg-Kimmel Institute for Cancer Immunotherapy; director, thoracic oncology program, professor of oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University.
For 17 years, the Winter Lung Cancer Conference has brought together world-class thoracic oncologists to share the best practices in the treatment of lung cancers. During this two-day program, attendees will have the chance to learn from and interact with international experts in several therapeutic areas, including immunotherapy, targeted agents, and multidisciplinary approaches. This conference provides the most cutting-edge research and practical information for the care of their patients, as well as offer a preview of new agents and techniques that will inform the future of lung cancer treatment. Throughout the program, question-and-answer sessions will also provide attendees with the opportunity to consult with faculty and their community-based peers.